EmQuest - Identifying factors which predict for health-related quality of life deficits and increased symptom burden in women who have been treated for endometrial cancer.
Dear Colleagues, Today we are excited to announce 16 speakers who will form part of the GAP 2020 conference program. With the final program to be announced in the New Year. Joining us from America and MD Anderson Cancer Centre: Patrick Hwu, MD Jeffrey E. Gershenwald, MD Kathleen M. Schmeler, MD...
Peter Mac scientists have found a way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.
Prof Sherene Loi, Prof Grant McArthur and Prof Ben Solomon have been included in the worldwide annual Web Of Science Highly Cited Researchers 2019 list.
A study has confirmed the accuracy of iPrevent, an online tool developed at Peter Mac to help women understand and reduce their risk of breast cancer. The study of almost 16,000 women, published in JNCI Cancer Spectrum, found iPrevent gave accurate predictions of their breast cancer risk over a ten-year period.
Peter Mac researchers have been awarded over $10 million dollars in funding from the National Health and Medical Research Council to undertake world-leading cancer research.
Cellular immune therapies are revolutionising cancer treatment and have been especially effective at combating blood cancers; now a team at Peter Mac and Monash Biomedicine Discovery Institute (BDI), led by Professor Tony Tiganis, may have found a way to extend this therapy to the treatment of solid tumours.
Specialised immune cells, capable of killing off infections and cancers, can escape their own destructive properties through the action of a protective outer shield, researchers from Peter Mac and the University College London have discovered.